MORE►
RLT
Novartis breaks ground on its Denton radioligand therapy site. [Photo: Novartis]
Switzerland-Based Novartis Breaks Ground on Radioligand Therapy Site in Denton
by Sandra Engelland | May 12, 2026
When completed in 2028, the company’s first Texas‑based manufacturing facility will bring RLT medications closer to patients across the southern United States, becoming the fifth RLT site nationwide, Novartis said.
by Sandra Engelland |
Feb 25, 2026
The purpose-built radiopharmaceutical site is the company’s fifth in the U.S. and the first manufacturing facility in Texas. It's expected to create new jobs in bioengineering, advanced manufacturing, quality, and operations.
MORE►
